Monday, November 2

The US Food and Drug Administration on Monday approved a low-cost version of a twice-yearly HIV prevention shot, bringing the breakthrough drug closer to market in low-income countries. The tentative approval was announced by the Indian maker of the generic version of lenacapavir, Dr. Reddy’s…

EDITOR'S PICK

Business

Politics

Tech & Innovation

Health